Source: PR Newswire

Press Release: Ablacon : Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark

MENLO PARK, Calif., Sept. 10, 2019 /PRNewswire/ -- Ablacon, Inc. (www.ablacon.com), an Ajax Health-funded company, announced today the release of an updated version of its Ablamap technology under the company's existing CE Mark. The new update includes an enhanced physician experience and...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Martin Grasse's photo - CEO of Ablacon

CEO

Martin Grasse

CEO Approval Rating

90/100

Read more